2013Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

The Effect Observation of Metformin Combined with Sitagliptin in Treatment of Early Type 2 Diabetes Mellitus

Yang Qun-fen

Open publisher page 1 citations

Abstract

Objective To observe curative effect of metformin combined with sitagliptin in treatment of early type 2 diabetes mellitus.Methods From November 2008 to November 2012 in our hospital treated 160 cases of early type 2 diabetic patients,which were randomly divided into study group and control group,the study group using metformin and sitagliptin treatment,control group with single metformin treatment,compared two groups of patients before and after treatment,2 months,4 months of glycemic control and adverse reaction.Results The two groups before treatment,fasting blood glucose(FBG),2h postprandial plasma glucose(2hPBG) and glycosylated hemoglobin(HbA1c),there was no significant difference(P 0.05);treatment of 2 months and 4 months after the index,the study group than in the control group,the difference was statistically significant(P 0.05);the study group and the control group in the treatment of adverse reaction incidence rates were 7.5% and 8.8%,the difference between the two groups was not statistically significant(P 0.05).Conclusion Metformin combined with sitagliptin treatment of type 2 diabetes curative effect,less adverse reaction,is worth the clinical promotion.

About this research paper

What this paper is about

Objective To observe curative effect of metformin combined with sitagliptin in treatment of early type 2 diabetes mellitus.Methods From November 2008 to November 2012 in our hospital treated 160 cases of early type 2 diabetic patients,which were randomly divided into study group and control group,the study group using metformin and sitagliptin treatment,control group with single metformin treatment,compared two groups of patients before and after treatment,2 months,4 months of glycemic control and adverse reaction.Results The two groups before treatment,fasting blood glucose(FBG),2h postprandial plasma glucose(2hPBG) and glycosylated hemoglobin(HbA1c),there was no significant difference(P 0.05);treatment of 2 months and 4 months after the index,the study group than in the control group,the difference was statistically significant(P 0.05);the study group and the control group in the treatment of adverse reaction incidence rates were 7.5% and 8.8%,the difference between the two groups was not statistically significant(P 0.05).Conclusion Metformin combined with sitagliptin treatment of type 2 diabetes curative effect,less adverse reaction,is worth the clinical promotion.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe curative effect of metformin combined with sitagliptin in treatment of early type 2 diabetes mellitus.Methods From November 2008 to November 2012 in our hospital treated 160 cases of early type 2 diabetic patients,which were randomly divided into study group and control group,the study group using metformin and sitagliptin treatment,control group with single metformin treatment,compared two groups of patients before and after treatment,2 months,4 months of glycemic control and adverse reaction.Results The two groups before treatment,fasting blood glucose(FBG),2h postprandial plasma glucose(2hPBG) and glycosylated hemoglobin(HbA1c),there was no significant difference(P 0.05);treatment of 2 months and 4 months after the index,the study group than in the control group,the difference was statistically significant(P 0.05);the study group and the control group in the treatment of adverse reaction incidence rates were 7.5% and 8.8%,the difference between the two groups was not statistically significant(P 0.05).Conclusion Metformin combined with sitagliptin treatment of type 2 diabetes curative effect,less adverse reaction,is worth the clinical promotion.

Key concepts: Medicine, Sitagliptin, Metformin, Postprandial, Glycemic, Internal medicine, Adverse effect, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
The Effect Observation of Metformin Combined with Sitagliptin in Treatment of Early Type 2 Diabetes Mellitus — Research Paper | ScholarLens